Published in J Emerg Nurs on January 28, 1982
Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol (1996) 2.21
Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy. Gynecol Oncol (1997) 1.57
Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol (1996) 1.54
Specificity of increased renal clearance of amylase in diagnosis of acute pancreatitis. N Engl J Med (1975) 1.50
Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep (1979) 1.50
Prognostic significance of DNA content in epithelial ovarian cancer. Gynecol Oncol (1994) 1.43
Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms. Obstet Gynecol (1994) 1.42
Endometrial cancer in women 40 years old or younger. Gynecol Oncol (2001) 1.20
Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. Clin Cancer Res (1999) 1.20
Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol (1993) 1.20
Epithelial ovarian carcinoma in the reproductive age group. Cancer (1999) 1.12
Müllerian inhibiting substance as a marker for ovarian sex-cord tumor. N Engl J Med (1992) 1.11
Intensive surgical and chemotherapeutic management of advanced ovarian cancer. Surg Clin North Am (1978) 1.10
The clinical utility of liposomal doxorubicin in recurrent ovarian cancer. Gynecol Oncol (2001) 1.10
Characterization of a xenograft model of human ovarian carcinoma which produces intraperitoneal carcinomatosis and metastases in mice. Int J Cancer (1996) 1.05
The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol (1996) 0.98
Epithelial ovarian tumors of borderline malignancy: long-term follow-up. Gynecol Oncol (1993) 0.97
Squamous cell carcinoma of the endometrium: a report of eight cases and a review of the literature. Gynecol Oncol (1996) 0.96
Prognostic implication of endometriosis in clear cell carcinoma of the ovary. Gynecol Oncol (2008) 0.96
Stage IE primary malignant lymphomas of the uterine cervix. Cancer (1991) 0.94
Female adnexal tumor of probable Wolffian origin with multiple recurrences over 16 years. Cancer (1985) 0.94
Surgical stage IV endometrial carcinoma: a study of 47 cases. Gynecol Oncol (1994) 0.93
Toxic-shock syndrome. N Engl J Med (1980) 0.92
Patterns of pulmonary metastasis from uterine cancer. Oncology (1996) 0.92
Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay. Gynecol Oncol (1985) 0.91
Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors. Gynecol Oncol (1999) 0.91
Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases. Gynecol Oncol (1995) 0.89
Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line. J Clin Endocrinol Metab (1982) 0.88
Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis. Obstet Gynecol (2000) 0.87
Malignant mixed müllerian tumors of the ovary: experience with surgical cytoreduction and combination chemotherapy. Cancer (1995) 0.87
Natural history of patients with pulmonary metastases from uterine cancer. Cancer (1996) 0.87
Primary treatment of Bartholin's gland carcinoma with radiation and chemoradiation: a report on ten consecutive cases. Int J Gynecol Cancer (2007) 0.85
Intraoperative radiation therapy in the treatment of pelvic gynecologic malignancies: a review of fifteen cases. Gynecol Oncol (2000) 0.84
Quality of life in advanced ovarian cancer: identifying specific concerns. J Palliat Med (1999) 0.84
Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice. Ann Surg (1981) 0.83
Fallopian tube prolapse after hysterectomy. A report of two cases. J Reprod Med (1988) 0.82
Pulmonary resection for metastases from gynecologic cancers: Massachusetts General Hospital experience, 1943-1982. Gynecol Oncol (1985) 0.82
Lymph node metastases from carcinoma of the cervix, stages IB and IIA: implications for prognosis and treatment. Gynecol Oncol (1982) 0.82
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer. Gynecol Oncol (2006) 0.82
Predictors of recurrence in surgical stage II endometrial adenocarcinoma. Gynecol Oncol (1999) 0.81
Carcinosarcomas and mixed Müllerian tumors of the fallopian tube. Gynecol Oncol (1989) 0.80
Primary leiomyosarcoma of the fallopian tube. Gynecol Oncol (1993) 0.79
Ultrasound-guided intrauterine removal of intrauterine contraceptive devices in pregnancy. Obstet Gynecol (1988) 0.79
Müllerian inhibiting substance: gene structure and mechanism of action of a fetal regressor. Recent Prog Horm Res (1987) 0.79
Recurrent ovarian granulosa cell tumor: role of combination chemotherapy with report of a long-term response to a cyclophosphamide, doxorubicin and cisplatin regimen. Eur J Gynaecol Oncol (1990) 0.78
Combination chemotherapy in advanced adenocarcinoma of the fallopian tube. Gynecol Oncol (1991) 0.78
Clear cell adenocarcinoma of the vagina: a second primary in a diethylstilbestrol-exposed woman? Gynecol Oncol (1991) 0.78
Recurrent psammocarcinoma of the peritoneum with complete response to tamoxifen therapy. Gynecol Oncol (1998) 0.78
Müllerian inhibiting substance inhibition of a human endometrial carcinoma cell line xenografted in nude mice. Gynecol Oncol (1984) 0.77
A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer. Clin Cancer Res (1999) 0.77
Prognostic variables in the treatment of squamous cell carcinoma of the vulva. Gynecol Oncol (1986) 0.77
A Phase I-II study of 96-hour infusional topotecan and paclitaxel for patients with recurrent Müllerian tumors. Cancer (2001) 0.76
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours. Br J Cancer (2005) 0.75
The fluorescent cytoprint assay in gynecological malignancies and breast cancer. Methodology and results. Contrib Gynecol Obstet (1994) 0.75
Nodal metastasis is highly consistent in squamous cell carcinoma of the vulva. J Clin Oncol (2001) 0.75
Nodal metastasis is highly consistent in squamous cell carcinoma of the vulva. J Clin Oncol (2001) 0.75
Life-threatening complications in the gynecologic cancer patient. Curr Probl Cancer (1979) 0.75
Primary mucinous carcinoid tumor of the ovary. A case report. Int J Gynecol Pathol (1989) 0.75
Sarcomas of the uterine corpus: prognostic factors and treatment. Radiother Oncol (1984) 0.75
Management of high-grade stage I adenocarcinoma of the endometrium: hysterectomy following low dose external beam pelvic irradiation. Gynecol Oncol (1986) 0.75
Primary adenocarcinoma of the fallopian tube. Eur J Gynaecol Oncol (1989) 0.75
Detached ciliary tufts mistaken for peritoneal parasites: a warning. Rev Infect Dis (1988) 0.75
Role of the primary physician in the detection and treatment of gynecologic cancer. Prim Care (1981) 0.75
Postoperative management of patients with stage Ib endometrial carcinoma. Eur J Gynaecol Oncol (1996) 0.75
Immunity, trophoblast, and trophoblastic neoplasia. Clin Obstet Gynecol (1977) 0.75
Resolution of malignant ascites after intraperitoneal chemotherapy in women with carcinoma of the ovary. Surg Gynecol Obstet (1988) 0.75
Successful pregnancy after high-dose cyclophosphamide, carboplatinum, and taxol with peripheral blood stem cell transplant in a young woman with ovarian carcinoma. Gynecol Oncol (2001) 0.75
The DES syndrome and clear cell adenocarcinoma in young women. Cancer Nurs (1978) 0.75
Ovarian cancer cachexia--surgical interactions. Gynecol Oncol (1979) 0.75
A phase II study of fixed dose rate gemcitabine in patients with relapsed müllerian tumors. Int J Gynecol Cancer (2005) 0.75
Low-dose preoperative radiation therapy for adenocarcinoma of the endometrium. A pilot study. Cancer (1984) 0.75
Aggressive locally recurrent vulvar cancer: review of cases presented to Massachusetts General Hospital 1990 to present. Int J Gynecol Cancer (2005) 0.75
Successful long-term palliation of stage IV vulvar carcinoma with operation and bleomycin sulfate. Am J Obstet Gynecol (1978) 0.75
Toxic shock syndrome occurring in the luteal phase of the menstrual cycle. Am J Obstet Gynecol (1981) 0.75